Page last updated: 2024-08-24

triciribine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

triciribine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battistelli, M; Chiarini, F; Cocco, L; Evangelisti, C; Falcieri, E; Martelli, AM; McCubrey, JA; Ognibene, A; Pagliaro, P; Ricci, F; Tazzari, P1

Other Studies

1 other study(ies) available for triciribine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

ArticleYear
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia.
    Journal of cellular physiology, 2011, Volume: 226, Issue:3

    Topics: Autophagy; Caspase 9; Cell Death; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Mechanistic Target of Rapamycin Complex 1; Microscopy, Electron, Transmission; Multiprotein Complexes; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proteins; Proto-Oncogene Proteins c-akt; Ribonucleosides; Side-Population Cells; TOR Serine-Threonine Kinases; Transcription Factors; Vincristine

2011